A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
about
Update in lung cancer and mesothelioma 2012The path to routine use of genomic biomarkers in the cancer clinicThe impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysisStaging lymph node metastases from lung cancer in the mediastinumExploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosisThe expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohortsIs there clinical value to prognostic signatures in early-stage NSCLC?Yin Yang gene expression ratio signature for lung cancer prognosisLung Cancer Gene Signatures and Clinical PerspectivesCombining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancerCancer research: from prognostic genes to therapeutic targetsPrognostic value of microRNA expression in operable non-small cell lung cancer patientsIntegrated DNA Copy Number and Gene Expression Regulatory Network Analysis of Non-small Cell Lung Cancer MetastasisInhibition effect of a custom peptide on lung tumorsExploiting the noise: improving biomarkers with ensembles of data analysis methodologies.Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer.Prognostic factors in resected lung carcinomas.Advances in adjuvant systemic therapy for non-small-cell lung cancer.Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma.The evolving genomic classification of lung cancer.Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinomaAddressing overdiagnosis and overtreatment in cancer: a prescription for changeIdentification of reproducible gene expression signatures in lung adenocarcinoma.Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signaturePrognostic markers in lung cancer: is it ready for prime time?Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.Gene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis.Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utility.EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
P2860
Q24619675-7AA68B8D-4C17-40E5-9A28-7EE2FDBC5DB2Q26782733-A09586CB-011E-450C-B09D-BCF04016172DQ26861418-7257E133-9CF1-4BA1-99B4-D4FE16A015F1Q26863443-42B85E82-B311-4BA4-B4C5-D2599C432607Q28276344-EFE29205-2AA6-4124-ADBC-06CDBD29C3DCQ28383695-3470DC7F-2554-47C5-83D5-F5BA32CE84CAQ28384571-D326606E-9A49-4FC9-A9C9-88B275A9AB67Q28385778-EE7E3E00-9912-47C1-9A08-35B4169EA203Q28387769-8F55EEFE-31DC-44D1-895D-44411CDCBAABQ28388778-E60E031A-C5C7-4937-9CAC-AAC68600F68AQ28396195-F03B4F33-14D7-49F7-A19C-C668C7A1951CQ28396343-9C0580EA-B302-4F6C-A9BD-2F0CE9945A32Q28397049-41F9A33E-6228-4815-8DD3-FBDBD26562A2Q28543702-3A97983D-9419-4000-913E-7947E86F5806Q30536424-0398109E-9362-455A-99A1-5ADC23977D02Q33577838-CC21EF19-D897-493D-8172-40B5F2CB6E60Q33584831-387A504E-5CA1-4870-83C5-1D05FC5E0CBDQ33614113-3AD904FD-63B0-4078-81B5-EAF47A92537EQ33697964-63886D59-B1B6-4309-9D93-4EB983C859D1Q34031225-E6A10921-E780-467D-AEE8-DCF055D6D5DDQ34155998-C9378B54-D3BA-4CE4-8074-661C7FD81377Q34346323-9EB619B2-D95B-409B-8999-DA32315C9818Q34404209-5847FC16-4CBE-43EC-9512-139E0157A6E6Q34507856-3100C4DD-FC62-4AD6-AB56-6B499E716BB6Q34623884-C074C9B0-B724-441E-B0E3-24D0A9AF1001Q34743874-13DF877D-6821-4FC2-81A7-C2B4F05E2519Q34852043-9346ED36-591F-47E8-ADA0-CE0F0C946D83Q34957141-FF31C535-5329-4F37-AC49-2993123A4230Q34972375-71CABBF6-82DE-498A-9663-03D098E44ABFQ35067706-B00B0E4F-F970-4A87-95D1-96706D3B9E78Q35076226-24BFD507-4E87-4F07-91B9-DFDF39AB01D4Q35147865-5E67C777-125D-404E-AACF-AF27FD76BCD1Q35200402-FDED6E52-4A08-4E89-9317-B90F35A5382CQ35200413-44858160-6EC9-489F-8E96-9D192DACA681Q35200555-28785C31-1CE9-471E-918E-16880F6F634FQ35203271-111D7A90-5704-4BD0-95C4-BE48340F3879Q35228753-26CA88BE-EEDA-4E5A-A385-77782419A0DCQ35538902-18F54AF4-3012-4F88-8999-8ED05F75117BQ35680083-AA85E66C-4C7F-40D4-994F-AFDA6FBD912AQ35738659-E6BBB729-3DA8-4921-AD7B-D9A5EB359573
P2860
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A practical molecular assay to ...... ternational validation studies
@ast
A practical molecular assay to ...... ternational validation studies
@en
type
label
A practical molecular assay to ...... ternational validation studies
@ast
A practical molecular assay to ...... ternational validation studies
@en
prefLabel
A practical molecular assay to ...... ternational validation studies
@ast
A practical molecular assay to ...... ternational validation studies
@en
P2093
P2860
P1433
P1476
A practical molecular assay to ...... ternational validation studies
@en
P2093
Charles P Quesenberry
Che-Chung Yeh
David Berryman
David M Jablons
Fatemeh Ziaei
Huanrong Zhang
Huiling Li
P2860
P304
P356
10.1016/S0140-6736(11)61941-7
P407
P577
2012-01-27T00:00:00Z